[Current treatment of rheumatoid arthritis].

  title={[Current treatment of rheumatoid arthritis].},
  author={Philippe Carli and C{\'e}cile Landais and Marc Aletti and J.-M. Cournac and Elodie Poisnel and J F Paris},
  journal={La Revue de medecine interne},
  volume={30 12},
Over the past 10 years, the management of rheumatoid arthritis has been revolutionized. Early diagnosis is essential and should allow an early initiation of disease modifying anti-rheumatic drugs (DMARD), if possible within the first 3 three months after disease onset, aiming at disease remission and the best long-term prognosis. Recommendations for the prescription of synthetic and biologic DMARD (mainly anti-TNFalpha agents) are available since September 2007 [6] by HAS in France. The great… CONTINUE READING


Publications referenced by this paper.